Objective: To compare population-based metrics for assessing progress toward the US National HIV/AIDS Strategy (NHAS) goals.
Introduction
The US National HIV/AIDS Strategy (NHAS) proposes a population-based approach to HIV prevention that centers on efforts to ensure that persons living with HIV/ AIDS (PLWHA) are diagnosed soon after acquiring HIV, successfully link to sustained medical care, and begin effective antiretroviral therapy (ART) in accordance with national guidelines [1] . Several metrics have been used to evaluate late HIV diagnoses, engagement in care, and virologic suppression on the population level [2] [3] [4] [5] [6] [7] , and the NHAS outlines specific targets in each of these areas to achieve by 2015 [8] . Laboratory-based reporting of CD4 and HIV RNA (viral load) results to health departments make population-based monitoring of virologic suppression and engagement in care feasible.
However, variation in state reporting requirements currently prohibits a nationwide assessment using these data [9] , and to date, we are not aware of published state or local reports providing a comprehensive view of the data that will be used to measure the outcomes envisioned in the NHAS. We used surveillance data from King County, Washington to evaluate metrics of HIV testing, linkage to care, engagement in care, and virologic suppression. Here we present data on the state of the HIV care continuum in one US urban area and evaluate metrics designed to assess the care continuum. We sought to assess how varying assumptions affect estimates of the population's receipt of care in order to identify gaps in existing knowledge and deficiencies in the HIV surveillance system that might be addressed as the United States develops a population-based approach to monitoring HIV prevention and care.
Methods

Data sources
We examined data from two sources: Public Health -Seattle & King County's (PHSKC) enhanced HIV/AIDS reporting system (eHARS) [10] and, separately, the electronic database of the PHSKC One-on-One program. We limited analysis to events that occurred prior to January 2010 and were reported through December 2010. In September 2006, Washington state implemented name-based HIV case reporting and requirements that laboratories report all CD4 and viral load results to public health [11] . Prior to that time, Washington state had name-based AIDS reporting and a name-to-code HIV case reporting system. Variables in eHARS are defined according to US Centers for Disease Control and Prevention (CDC) criteria [3] . HIV testing history data, collected through case reports and the CDC Testing and Treatment History Questionnaire, are predominately self-reported. PHSKC staff attempt to provide partner services to all persons diagnosed with HIV in King County and attempt to ensure the completion of the questionnaire in that process. reported in the preceding year in order to identify persons who are out of HIV care and to ascertain outmigration and incomplete data reporting [12] .
PHSKC conducts efforts to improve the quality of
Because the completeness and validity of HIV surveillance data is not well defined, we sought to separately evaluate measures of timely HIV diagnosis through another source, the PSHKC One-on-One program. Participation in One-on-One is open to all persons with newly diagnosed HIV in King County, and is routinely offered to all persons diagnosed with HIV through PHSKC-funded programs. Persons diagnosed elsewhere can be referred to One-on-One by medical providers or disease intervention specialists providing HIV partner services. The program involves meeting with a physician for counseling, referral for HIV medical care, CD4 cell count and viral load testing and partner services. In 2009, 34% of persons diagnosed with HIV in King County were diagnosed at a PHSKC-funded testing site [13] , 82% of whom participated in One-on-One.
Outcome measures and populations
The measures of HIV testing, linkage to care, engagement in continuous care, and virologic suppression that we examined are defined in Table 1 [2-8], which distinguishes outcome measures included in the NHAS from those derived from other sources. We restricted analyses of the timing of HIV diagnosis and linkage to care to cases diagnosed in King County in 2005-2009, the most recent 5 years for which we had complete data. For analysis of linkage to and engagement in care, we used the dates of CD4 or viral load results as proxy measures for medical visits. We restricted the analysis of linkage to sustained care to HIV cases diagnosed in King County in 2007-2009 because 2007 was the first complete year of mandatory CD4 and viral load reporting in Washington state.
We examined indicators of engagement in continuous care and virologic suppression in the population of PLWHA presumed to reside in King County as of 31 December 2009. This included all persons known to have an HIV diagnosis in King County, regardless of their place of diagnosis, who were not known to have died or relocated. We defined virologic suppression as viral load 48 copies/ml or less at last report in 2009, and we calculated mean community viral load as the average of the last viral load reported in 2009 among all persons with at least one viral load reported in 2009 [7] .
Data analysis
We defined outcomes for each metric in Table 1 , analyzing and reporting data from eHARS and the Oneon-One program separately. Laboratory results obtained through the One-on-One program are included in eHARS. We did not attempt to exclude those results from the analysis of CD4 cell count at diagnosis because we wanted to evaluate this measure for the entire county, and we were unable to exclude them from analysis of linkage to care because the ordering source for some laboratory data in eHARS was not available. For analysis of intertest intervals (ITIs), we assumed that cases with a complete year but missing month of the last negative HIV test were tested in July, unless the test year was the same as the diagnosis year, in which case we assumed the last negative test was midway between January and the diagnosis month. We conducted a subset analysis of ITI limited to persons with a laboratory-confirmed date of last HIV negative test in the PHSKC STD clinic records. We excluded initial CD4 cell counts that were reported more than 6 months after the HIV-diagnosis date from analyses of CD4 cell count at diagnosis. Analyses of virologic suppression and CD4 stratification used the last viral load and CD4 cell count reported in 2009. CD4 strata (200, 200-350, 351-500, and >500 cells/ml) reflect thresholds used clinically in decisions regarding ART initiation [14] . For analyses comparing MSM vs. non-MSM, we classified injection drug using MSM as MSM and excluded persons with unknown transmission risk factors.
We used linear regression to assess associations between independent variables and continuous outcomes and logistic regression to assess associations between independent variables and binary outcomes. When evaluating nonnormally distributed continuous outcomes, we compared the results of nonparametric statistical tests (Kruskal-Wallis test, Wilcoxon rank-sum and Spearman's correlation) with parametric tests (Student's t-tests, oneway ANOVA, and linear regression); when results were similar, we report the results of parametric tests. We used Stata 10 for all analyses.
Results
HIV diagnosis metrics
A total of 1590 persons were diagnosed with HIV/AIDS in King County and 368 persons completed the One-on-One program in 2005-2009. Table 2 summarizes results for indicators of the timing of HIV diagnosis countywide (using eHARS data) and in the One-on-One program (see Table 1 (9) 34 (17) 34 (17) 33 (17) 26 (14) 140 (15) 34 (11) Intertest interval, median (IQR), months a 11 (5- during 2005-2009 countywide or in the One-on-One program (data not shown).
As shown in Fig. 1 Never tested ≤ 12 months 13-24 months 25-60 months 61-120 months > 120 months Never tested ≤ 12 months 13-24 months 25-60 months 61-120 months ≥ 120 months a Limited to the >95% or persons with ITI <120 months. with CD4 350 cells/ml, OR 0.64 (95% CI 0.45-0.90)]. There were no significant differences in linkage to sustained care by sex, race, or HIV risk factor (data not shown).
At the end of 2009, 6070 diagnosed PLWHA were presumed to reside in King County. Figure 2 shows the completeness of laboratory reporting, virologic suppression, and CD4 cell count distribution of these persons. Laboratory data were reported in 2009 for 81% of all PLWHA presumed to reside in the area. Among 1123 persons for whom no data were available in 2009, 495 (44%) had not had any data reported to surveillance for over 5 years (as Fig. 2 shows, 429 persons last had a CD4 or viral load result reported prior to 2005; 66 persons had no CD4 or viral load reported and were diagnosed with HIV prior to 2005). Compared with whites, African-Americans and Latinos were less likely to have had at least one viral load reported in 2009 [80 vs. 83%, OR 0.81 (95% CI 0.68-0.96) and 76 vs. 83%, OR 0.66 (95% CI 0.54-0.81), respectively]. The proportion of PLWHA without laboratory data in 2009 did not vary significantly by age, sex or HIV-transmission risk factor (data not shown).
Engagement in continuous care
The proportion of PLWHA engaged in continuous care (2 visits 3 months apart in 2009) depended substantially on the denominator we used to define engagement in care (Fig. 3) . Using the denominator of persons who had at least one visit in 2009, excluding those who established care in the second half of the year, which is the Health Resources and Services Administration (HRSA) definition used in the NHAS, 81% (3864 of 4762) were engaged in continuous care. Using a less restrictive denominator, the total number of PLWHA presumed to reside in King County at the end of 2009 (excluding those who established care in the second half of the year) 66% (3864 of 5885) were engaged in continuous care. Finally, assuming that persons with no data reported to HIV surveillance for 5 years were no longer in King County at the end of 2009 and, thus, eliminating them from the denominator, 72% (3864 of 5390) were engaged in continuous care.
Viral suppression
Of persons with at least one viral load reported in 2009, 65% had undetectable viral load at the time of last report. However, like estimates of engagement in care, estimates of virologic suppression varied substantially based on the denominator used. Including either all PLWHA not known to have died or left the area or all PLWHA for whom laboratory data were reported in the prior 5 years, 53 and 57%, respectively, had an undetectable viral load. Among persons with at least one viral load reported, compared with whites, African-Americans had lower odds of virologic suppression [62 vs. 66%, OR 0.85 (95% 
Discussion
We investigated surveillance measures for HIV testing, linkage to and engagement in care, and treatment in order to assess the current state of HIV care in King County, Washington and to evaluate metrics that public health agencies can monitor as they pursue the goals of the NHAS. As in other areas of the United States, we observed that a large proportion of persons diagnosed with HIV had AIDS within 1 year of HIV diagnosis [4] . However, we also found that the ITI, a metric used to estimate the time between HIVacquisition and diagnosis, yielded disparate results. Linkage to care was high, but it was not associated with subsequent virologic suppression, and many PLWHA appeared to fall out of care in the first year, suggesting that it may be important to monitor linkage to sustained HIV care. Finally, we found that estimates of engagement in care and virologic suppression were highly dependent on how we defined the population of PLWHA, highlighting the need for health departments to have up-to-date data on which PLWHA reside in their area if they propose to monitor engagement in care and viral suppression.
Our findings suggest that current metrics of late HIV diagnosis may yield incomplete information. The CD4 cell count at diagnosis was only weakly correlated with ITI (R 2 ¼ 0.07), and nearly one-third of persons diagnosed with AIDS within 1 year of HIV diagnosis reported testing HIV negative in the prior 2 years. Some persons with low CD4 cell counts and recent negative HIV tests may have had transient drops in CD4 cell count associated with acute infection, and prior studies have observed substantial variation in the rate of CD4 depletion that might explain the poor correlation we observed between CD4 cell count and ITI [15, 16] . Another possibility is that the HIV testing history collected through our surveillance system is invalid. This possibility is supported by our observation that the risk of AIDS diagnosis within 1 year of HIV diagnosis was much lower among persons for whom we had confirmed dates of last negative HIV tests (10%) -most of whom had tested relatively recently -than among all persons for whom we had testing history data. However, we had confirmed testing history for a relatively small number of persons. If AIDS diagnosis within 1 year of HIV diagnosis is a nonspecific indicator of late diagnosis, it might not be a sensitive metric for detecting improvements in testing frequency in the population. Given these uncertainties, we propose to continue monitoring both ITI and AIDS diagnosis within 1 year of HIV diagnosis and are attempting to more consistently collect laboratoryconfirmed testing history data for each new HIV case.
We also found that linkage to sustained care, but not linkage to initial care, was associated with virologic suppression, a clinically meaningful endpoint. These findings are consistent with previous clinic-based studies of linkage to and retention in HIV care [17, 18] , and argue for the importance of ensuring that persons with newly diagnosed HIV attend more than a single visit. On the basis of our findings, we believe that health departments should include explicit plans to monitor linkage to sustained care and should consider modifying outreach activities to ensure linkage beyond an initial clinical visit.
Our findings also highlight inadequacies in and difficulties using HIV surveillance data that affect our ability to monitor progress toward the NHAS goals. Approximately one-fifth of PLWHA presumed to reside in King County at the end of 2009 had no viral load results reported in 2009. This proportion is lower than that reported from San Francisco (26% missing viral load alone) [7] , Washington, DC (52% missing) [19] and New York (43% missing) [20] . The population missing laboratory results reflects a combination of persons who are out of care, incomplete capture of laboratory data, and unascertained outmigration and death. Our estimates of care engagement and virologic suppression were highly dependent on assumptions we adopted about the status of persons with no recent data in surveillance. The implementation plan for the NHAS focuses on engagement in care among Ryan White clients and uses the HRSA definition of engagement in care, which considers only persons with at least one medical visit in a year. The advantage of this approach is that it represents a reproducible metric for a definable population and should allow comparisons across jurisdictions. However, the metric is not population-based and is liable to overestimate the health system's success in providing care to PLWHA because it disregards persons out of care. It also disregards those receiving care outside of the Ryan White program, a sizeable population from which few data are available regarding patterns of engagement in care. Surveillance data have the substantial advantage of being population-based, but the use of such data is currently hampered by uncertainty about which PLWHA reside in an area, the population in which such estimates must be derived. The US HIV surveillance system is evolving from its past focus on counting and describing new HIV/AIDS diagnoses to a broader focus that includes monitoring the receipt of health services and guiding interventions to improve health outcomes [21] . Doing this successfully will require ongoing efforts to ascertain migration between jurisdictions, which in turn requires uniformity in state requirements for CD4 and viral load reporting.
This study had important limitations. We had incomplete testing history data for a substantial portion of the population. In Washington, as in other states with comprehensive reporting requirements for CD4 and viral load results, collection of these data has not been robustly validated. Finally, the accuracy of laboratory result dates as proxies for medical visit dates has not been validated, and we may have overestimated retention in care by including tests sent from settings other than primary HIV care visits.
The release of the NHAS was a critical step in advancing a coordinated, population-based plan to prevent HIV infections and provide effective medical care to PLWHA in the United States. Our findings highlight the fact that many PLWHA are diagnosed after their infection is clinically advanced, linkage to sustained care is inadequate, and many PLWHA appear not to be engaged in continuous care. Efforts to monitor progress toward the achievement of the goals defined by the NHAS will require substantial improvements in HIV surveillance and efforts to refine the metrics used to measure HIV testing, engagement in care, and virologic suppression.
